A majority of the proceeds raised would go toward "general corporate purposes," which could mean anything from research and development to investments in other healthcare companies.  

Scientists believe this is the first series demonstrating a significant survival difference in patients monitored with an intensive follow-up strategy via 18F-fludeoxyglucose–positron emission tomography.  

Scientists at Houston Methodist Hospital developed the intelligent-augmented breast cancer risk calculator, testing it across a large dataset to produce promising results. 

“This situation unacceptably exacerbates the interventional cardiology workforce shortage and threatens to directly impact the care of patients," SCAI wrote in a new statement. 

It may be necessary to monitor physicians' average daily productivity numbers over more extended periods of time to address this issue. 

James McGuckin, MD, most recently made the news in May when the DOJ filed suit against him and his affiliated practices. 

Buzzworthy developments of the past few days.

“Until there is a global consensus on how this is regulated, Asian countries—where data privacy is less of a focus—could see a clear contrast with the West in how AI is used.”